NeuroPace Inc
NeuroPace, Inc. (Nasdaq: NPCE) develops and sells medical devices for people with epilepsy, with its business focused on the RNS System, a brain-responsive neuromodulation system for adults with drug-resistant focal epilepsy in the United States. The implanted system monitors brain activity, detects patient-specific… From the company’s description.
Over the twelve months to Jun 30, 2026, NeuroPace Inc reported revenue of $98.77M, up 11.5% from a year earlier, and a net loss of $19.11M. Its operating margin was −15.3%, and operations used $11.24M in cash. In fiscal 2025, it reported revenue of $99.99M, up 25.1% from fiscal 2024, and a net loss of $21.46M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What NeuroPace Inc does
In the company’s own words
NeuroPace, Inc. (Nasdaq: NPCE) develops and sells medical devices for people with epilepsy, with its business focused on the RNS System, a brain-responsive neuromodulation system for adults with drug-resistant focal epilepsy in the United States. The implanted system monitors brain activity, detects patient-specific patterns associated with seizures, and delivers targeted electrical stimulation; it also records brain data that clinicians can review in person or remotely to guide care. The system includes an implanted neurostimulator and leads, patient monitoring equipment, clinician programming tools, and software platforms for data management and patient reporting. Its customers include hospitals and epilepsy centers, as well as prescribing epileptologists and implanting neurosurgeons; patients receive the device through clinical care. NeuroPace also pursues studies of potential expanded uses, including generalized epilepsy and treatment of patients under 18. As of December 31, 2025, more than 8,000 patients had received the system, and its database contained over 22 million brain activity records. Its website is www.neuropace.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- MOUNTAIN VIEW, CA
- Fiscal year end
- December
- CIK
- 1528287
- SIC
- 3841
Financial performance, year by year
Fiscal 2021–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns NeuroPace Inc — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · NeuroPace Inc’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do NeuroPace Inc and its peers compare on margins and cash generation over ten years?”
- “Where did five years of NeuroPace Inc's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in NeuroPace Inc's last four quarterly filings that the numbers alone won't show?”